akkshay11

TORRENT PHARMA

akkshay11 Updated   
NSE:TORNTPHARM   TORRENT PHARM
TORNTPHARM

THE WAY IT HAS TURNED FROM 3000, 2830 SEEMS TO BE THE SUPPORT

IF IT DOES NOT STOP HERE, THE DOWNSIDE LEVELS WILL BE 2810, 2775, & 2750

IF SUPPORT HOLD IT MIGHT HEAD BACK TO 2880 AND MAYBE 2910


******************************************************************************************************************************************************************
Hi all,

Its pleasure to have you all here.

I have started putting these charts as a contribution from my side to all people who are new to business, as I had to struggle a lot without any sources at disposal. So please consider this a just small contribution from my side.

Few Honest Disclosures:

1. Any idea shared is my personal view, its not a recommendation, neither any kind of paid propaganda, so please
do your bit of research.
2. Ideas shared does not mean that I trade all or have position in them, this is just a helping hand to all.
3. I expect no comments or like nor any negativity, as I said its just a small helping hand from my side, please plan your risk and trade as per your capacity.
4. To trade in Cash, options or futures is your sole choice and your own risk
5. I am no expert in Tech Indicators, I believe in support resistance and trendline theory, you may use this as a supplement theory for better results.
6. I work for my own living, this is a hobby which I do sincerely to help anyone who might come across my charts.

***********************************************************************************************************************************************
Trade active:
First it hit the stop loss, but once it broke 2830, it never recovered, if stays below can achieve the levels.
Trade active:
#levelsdontlie

Once it breached our support, it never turned back and straight 50 pts :)

First target done :)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.